Is Finerenone effective in treating proteinuria?

Finerenone (Finerenone), a drug used to treat diabetes-related kidney disease, may have a positive effect on protein in the urine (albuminuria) to some extent. Its mechanism of action mainly involves the antagonism of aldosterone receptors, thereby slowing down the progression of diabetes-related kidney diseases by protecting the kidneys and reducing inflammation.

Diabetic nephropathy is a common complication. One of its characteristics is an increase in urinary protein, which may lead to a gradual decline in kidney function. Clinical trials of fenelidone have shown that in some patients it can significantly reduce urinary protein levels, thereby reducing the burden on the kidneys and protecting kidney function.

However, the therapeutic effects of fenelidone may vary between patients, depending on factors such as disease severity, individual differences, and treatment regimen. In some studies, fenelidone has been found to be significantly more effective than placebo in reducing urinary protein levels. However, each patient's response is unique, and the effects of treatment may take time to appear.

Overall, the effectiveness of fenelidone in treating diabetes-related kidney disease has been positive in some patients, reducing urinary protein levels and thus protecting kidney function. However, as a new type of drug, its therapeutic effect is still being verified in continuous clinical research and practice. If you are concerned about proteinuria or are receiving treatment, it is recommended that you work closely with your doctor for regular follow-up and monitoring to ensure the effectiveness of your medications and changes in your kidney health.

Fenelidone is currently on the market in China and has been included in medical insurance. Patients can purchase it at domestic hospital pharmacies. For specific prices and prices after medical insurance reimbursement, please consult the local hospital pharmacy. Overseas, the main Japanese original drug is fenelidone, with a specification of 10mg*100 tablets of about more than 2,000 yuan, and it is the same as the domestic original drug.